babyark Launches at Bloomingdale’s, Marking Another Milestone in the Company’s Explosive Retail Growth

babyark, the innovative car seat brand committed to reimagining child safety through advanced technology and design, is now available at Bloomingdales.com. Partnering with Bloomingdale's-a legacy name in American retail-marks a milestone in babyark's mission to make cutting-edge safety and design more accessible to parents seeking premium products in the digital age. “We're thrilled to partner […]

FirstBank’s Cube Hunt Campaign Surprises Communities and Supports Small Businesses

LAKEWOOD, Colo., July 01, 2025 (GLOBE NEWSWIRE) — FirstBank, one of the nation's largest privately held banks with a focus on “banking for good,” is bringing a wave of excitement to Colorado this summer with its “our cube means business” campaign. From July 11 through September 5, Coloradans will be provided hints and urged to

FirstBank’s Cube Hunt Campaign Surprises Communities and Supports Small Businesses

FirstBank's Cube Hunt Campaign Surprises Communities and Supports Small Businesses Find the FirstBank Cube at nine business storefronts and score giveaways GlobeNewswire July 01, 2025 LAKEWOOD, Colo., July 01, 2025 (GLOBE NEWSWIRE) — FirstBank, one of the nation's largest privately held banks with a focus on “banking for good,” is bringing a wave of excitement

TimberHP Exits Chapter 11 with Strengthened Balance Sheet, Roadmap for Long-Term Financial Stability and Growth

Company emerges with $21 million in new working capital; Cianbro remobilized on-site in Madison for completion of TimberBoard manufacturing line. TimberHP, the sole manufacturer of wood fiber insulation in North America, announced today its successful emergence, uncontested, from Chapter 11, allowing the recapitalized company to operate from a position of strength as it executes its

Juniper Networks’ Marvis(R) AI Assistant Wins 2025 Artificial Intelligence Breakthrough Award

LOS ANGELES, July 01, 2025 (GLOBE NEWSWIRE) — AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Juniper Networks, a leader in secure, AI-native networking, has been selected as winner of the “Virtual Agent Solution of the Year” award

Juniper Networks’ Marvis(R) AI Assistant Wins 2025 Artificial Intelligence Breakthrough Award

Juniper Networks' Marvis(R) AI Assistant Wins 2025 Artificial Intelligence Breakthrough Award Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions GlobeNewswire July 01, 2025 LOS ANGELES, July 01, 2025 (GLOBE NEWSWIRE) — AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI)

Pan-African Progressive Front opens headquarters in Accra

The Pan-African Progressive Front (PPF) has chalked up a significant milestone with the official inauguration of its headquarters in Accra, marking what the organisers describe as a turning point in the ongoing struggle for African unity and self-determination. The historic launch on Monday, June 30, 2025 drew a strong presence of dignitaries, activists, intellectuals and

Join Class Action to Recover Losses from Iovance Biotherapeutics, Inc. (IOVA) – Contact Levi & Korsinsky Before July 14, 2025

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=155118&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

ATTENTION Altimmune, Inc. (ALT) Investors: Possible Fraud – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Altimmune, Inc. ("Altimmune, Inc.") (NASDAQ:ALT) concerning possible violations of federal securities laws. Altimmune announced topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH), revealing that the

Scroll to Top